PHOENIX, May 31, 2016 /PRNewswire/ -- Lotus Bio-Technology Development Corp (OTC: LBTD), (the "Company") is pleased to announce that on May 7, 2016 the Company has signed a strategic exclusive, joint development and marketing agreement with Hunan Cangshi Biological Technology Co. Ltd (HC), to bolster sales and operate synergistically toward the strengthening of the Company's position in the industry.
"This is a real turning point for us. The relationship with HC represents a significant opportunity to collaborate with a true breakthrough company with aligned values and a similar mission. We plan to advance together expediently in creating sustainable and natural consumer related products," said Michael Palethorpe, President of Lotus. "They are a choice partner with deep industry roots that will enable us to accelerate our international sales strategy at a time when China is at the fore-front of a new revolution; the growing market acceptance of environmentally friendly products."
Hunan Cangshi is a successful proprietor, developer and producer of a line of consumer related products that are made entirely with organic based plants that are grown under the direction and control of HC. HC specializes in the development of organic based, consumer driven, environmentally friendly products that boast quality and affordability.
Under the terms of the agreement, Lotus and HC will jointly and exclusively promote the entire line of quality products and services that are currently produced by HC. Lotus will offer their marketing expertise resources and HC will provide the products and services to create a synergistic relationship that will increase the chances of sales success in the emerging natural products markets in China. In addition, HC will continue to innovate and develop new products with the assistance of Lotus.
Lotus Bio-Technology has diligently established long-term relationships and strategic partnership with various biological companies and medical distribution companies in China, including Phyto Nutraceutical Inc., which is developer, manufacturer, exporter and primary supplier of plant extracts and Changsha Huakang Biotechnology Development Co., Ltd, a company which specializes in extracting active ingredient from natural herbs and plants. Lotus also collaborates closely with Shanghai Ninth People's Hospital and Shanghai Putuo People's Hospital and as their direct supplier, the Company provides patients with premium quality of organic consumer products.
About Lotus Bio-Technology Development Corp. Lotus Bio-Technology is an Arizona based bio-technology development company that specializes in the refining of organic materials and the production of natural consumer related products. The Company has the rights to farmland in China of 1,000 hectares, which are approximately 100 football fields combined. Our mandate is to grow various plants under strict organic standards and produce organic based consumer related products which completely are natural. The products will strike a balance between affordability and produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones or other dangerous chemicals while ensuring a solid financial return for our shareholders. The Company is a publicly traded company having its common shares quoted on the OTC Markets under the symbol LBTD.
Cautionary Note Regarding Forward-Looking Statements: This news release contains forward-looking statements about our business or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lotus-bio-technology-enters-joint-development-and-marketing-agreement-with-successful-proprietor-developer-and-producer-of-organic-consumer-products-300276789.html
SOURCE Lotus Bio-Technology Development Corp